Terapia con microinfusore e sensore della glicemia in continuo nei bambini con diabete di tipo 1… guardando al futuro!

Translated title of the contribution: Insulin pump therapy plus glucose sensing for continuous glocose monitoring in children with type 1 diabetes: What will come next?

Andrea Scaramuzza, R. Bonfanti, R. Schiaffini

Research output: Contribution to journalArticle

Abstract

The first instrument that measured blood sugar “continuously” appeared 15 years ago. Since then, subcutaneous glycemic sensors have made it possible to obtain continuous blood glucose measurements, giving physicians or patients real-time pictures of the levels of sugar in the blood. The quality of the technology has substantially improved – in the measurement and interpretation of results – although much remains to be done, especially as regards the sensors’ accuracy and reliability. Some very important studies (RealTrend, Eurythmics, ONSET, SWITCH, STAR 3, INTERPRET) have confirmed that continuous glucose monitoring contributes added value to insulin therapy, especially when an insulin pump is used, to achieve therapeutic goals. For almost ten years now it has been possible to combine the pump with a blood glucose sensor, giving what is known as sensor-augmented insulin pump therapy. In the last two years, the findings from other studies have been published, with important updates on blood glucose monitoring implemented with automatic suspension of the insulin infusion as soon as a predetermined threshold is achieved (ASPIRE) or even in relation to the expectation that the threshold will soon be reached (PILGRIM).

Original languageItalian
Pages (from-to)133-138
Number of pages6
JournalGiornale Italiano di Diabetologia e Metabolismo
Volume34
Issue number3
Publication statusPublished - Sep 1 2014

Fingerprint

Type 1 Diabetes Mellitus
Blood Glucose
Insulin
Glucose
Therapeutics
Suspensions
Technology
Physicians

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

@article{b4651ace4878418281ca690976d5757a,
title = "Terapia con microinfusore e sensore della glicemia in continuo nei bambini con diabete di tipo 1… guardando al futuro!",
abstract = "The first instrument that measured blood sugar “continuously” appeared 15 years ago. Since then, subcutaneous glycemic sensors have made it possible to obtain continuous blood glucose measurements, giving physicians or patients real-time pictures of the levels of sugar in the blood. The quality of the technology has substantially improved – in the measurement and interpretation of results – although much remains to be done, especially as regards the sensors’ accuracy and reliability. Some very important studies (RealTrend, Eurythmics, ONSET, SWITCH, STAR 3, INTERPRET) have confirmed that continuous glucose monitoring contributes added value to insulin therapy, especially when an insulin pump is used, to achieve therapeutic goals. For almost ten years now it has been possible to combine the pump with a blood glucose sensor, giving what is known as sensor-augmented insulin pump therapy. In the last two years, the findings from other studies have been published, with important updates on blood glucose monitoring implemented with automatic suspension of the insulin infusion as soon as a predetermined threshold is achieved (ASPIRE) or even in relation to the expectation that the threshold will soon be reached (PILGRIM).",
keywords = "Adolescents, Children, Continuous glucose monitoring, Glycemic sensor, Insulin pump, Insulin therapy, Type 1 diabetes",
author = "Andrea Scaramuzza and R. Bonfanti and R. Schiaffini",
year = "2014",
month = "9",
day = "1",
language = "Italian",
volume = "34",
pages = "133--138",
journal = "Giornale Italiano di Diabetologia",
issn = "1593-6104",
publisher = "UTET Periodici Scientifici srl",
number = "3",

}

TY - JOUR

T1 - Terapia con microinfusore e sensore della glicemia in continuo nei bambini con diabete di tipo 1… guardando al futuro!

AU - Scaramuzza, Andrea

AU - Bonfanti, R.

AU - Schiaffini, R.

PY - 2014/9/1

Y1 - 2014/9/1

N2 - The first instrument that measured blood sugar “continuously” appeared 15 years ago. Since then, subcutaneous glycemic sensors have made it possible to obtain continuous blood glucose measurements, giving physicians or patients real-time pictures of the levels of sugar in the blood. The quality of the technology has substantially improved – in the measurement and interpretation of results – although much remains to be done, especially as regards the sensors’ accuracy and reliability. Some very important studies (RealTrend, Eurythmics, ONSET, SWITCH, STAR 3, INTERPRET) have confirmed that continuous glucose monitoring contributes added value to insulin therapy, especially when an insulin pump is used, to achieve therapeutic goals. For almost ten years now it has been possible to combine the pump with a blood glucose sensor, giving what is known as sensor-augmented insulin pump therapy. In the last two years, the findings from other studies have been published, with important updates on blood glucose monitoring implemented with automatic suspension of the insulin infusion as soon as a predetermined threshold is achieved (ASPIRE) or even in relation to the expectation that the threshold will soon be reached (PILGRIM).

AB - The first instrument that measured blood sugar “continuously” appeared 15 years ago. Since then, subcutaneous glycemic sensors have made it possible to obtain continuous blood glucose measurements, giving physicians or patients real-time pictures of the levels of sugar in the blood. The quality of the technology has substantially improved – in the measurement and interpretation of results – although much remains to be done, especially as regards the sensors’ accuracy and reliability. Some very important studies (RealTrend, Eurythmics, ONSET, SWITCH, STAR 3, INTERPRET) have confirmed that continuous glucose monitoring contributes added value to insulin therapy, especially when an insulin pump is used, to achieve therapeutic goals. For almost ten years now it has been possible to combine the pump with a blood glucose sensor, giving what is known as sensor-augmented insulin pump therapy. In the last two years, the findings from other studies have been published, with important updates on blood glucose monitoring implemented with automatic suspension of the insulin infusion as soon as a predetermined threshold is achieved (ASPIRE) or even in relation to the expectation that the threshold will soon be reached (PILGRIM).

KW - Adolescents

KW - Children

KW - Continuous glucose monitoring

KW - Glycemic sensor

KW - Insulin pump

KW - Insulin therapy

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84908123232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908123232&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:84908123232

VL - 34

SP - 133

EP - 138

JO - Giornale Italiano di Diabetologia

JF - Giornale Italiano di Diabetologia

SN - 1593-6104

IS - 3

ER -